Literature DB >> 23441140

How predictive of dementia are peripheral inflammatory markers in the elderly?

Andrea L Metti1, Jane A Cauley.   

Abstract

Dementia is a huge public health concern today owing to the exponentially increasing number of older adults it affects each year, and there has been a large number of investigators looking at potential biomarkers of dementia. Peripheral inflammatory markers have emerged as one potential class of markers that may be useful in predicting those individuals at a greater risk of developing dementia, or in expounding the underlying mechanisms or pathways of this complex disease. Although some evidence has been promising, indicating that peripheral inflammatory markers are indeed crucial in brain changes that occur in both normal aging and in dementia, results have been mixed on their usefulness for predicting dementia or cognitive decline in older adults. Here, the authors present a review of existing studies investigating inflammatory markers as potential biomarkers of dementia, highlighting some strengths and limitations of the current research and discuss the future directions for this field.

Entities:  

Year:  2012        PMID: 23441140      PMCID: PMC3579631          DOI: 10.2217/NMT.12.68

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  62 in total

Review 1.  Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent?

Authors:  R Dantzer; J P Konsman; R M Bluthé; K W Kelley
Journal:  Auton Neurosci       Date:  2000-12-20       Impact factor: 3.145

2.  Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging.

Authors:  Giovanni Ravaglia; Paola Forti; Fabiola Maioli; Martina Chiappelli; Fausta Montesi; Emanuela Tumini; Erminia Mariani; Federico Licastro; Christopher Patterson
Journal:  Neurobiol Aging       Date:  2006-09-29       Impact factor: 4.673

3.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

4.  Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.

Authors:  Markus Britschgi; Kaspar Rufibach; Sarah L Bauer Huang; Christopher M Clark; Jeffrey A Kaye; Ge Li; Elaine R Peskind; Joseph F Quinn; Douglas R Galasko; Tony Wyss-Coray
Journal:  Mol Cell Proteomics       Date:  2011-07-08       Impact factor: 5.911

Review 5.  Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group.

Authors: 
Journal:  Neurobiol Aging       Date:  1998 Mar-Apr       Impact factor: 4.673

6.  Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

Authors:  F Licastro; S Pedrini; L Caputo; G Annoni; L J Davis; C Ferri; V Casadei; L M Grimaldi
Journal:  J Neuroimmunol       Date:  2000-02-01       Impact factor: 3.478

7.  Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study.

Authors:  Brenda W J H Penninx; Stephen B Kritchevsky; Kristine Yaffe; Anne B Newman; Eleanor M Simonsick; Susan Rubin; Luigi Ferrucci; Tamara Harris; Marco Pahor
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

8.  Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein.

Authors:  D I Chasman; P Kozlowski; R Y Zee; D J Kwiatkowski; P M Ridker
Journal:  Genes Immun       Date:  2006-04       Impact factor: 2.676

9.  Elevated serum C-reactive protein relates to increased cerebral myoinositol levels in middle-aged adults.

Authors:  Danielle E Eagan; Mitzi M Gonzales; Takashi Tarumi; Hirofumi Tanaka; Sandra Stautberg; Andreana P Haley
Journal:  Cardiovasc Psychiatry Neurol       Date:  2012-02-22

10.  Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.

Authors:  Daniel Johnstone; Elizabeth A Milward; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

View more
  7 in total

1.  Rare Variants and Transcriptomics in Alzheimer disease.

Authors:  Crystal Humphries; Martin A Kohli
Journal:  Curr Genet Med Rep       Date:  2014-06-01

Review 2.  Longitudinal inflammation, cognitive decline, and Alzheimer's disease: a mini-review.

Authors:  B M Bettcher; J H Kramer
Journal:  Clin Pharmacol Ther       Date:  2014-07-10       Impact factor: 6.875

Review 3.  Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.

Authors:  Carlo Cervellati; Giuseppe Valacchi; Veronica Tisato; Giovanni Zuliani; Judit Marsillach
Journal:  Minerva Med       Date:  2018-10-11       Impact factor: 4.806

4.  Longitudinal Associations Between Serum Cytokine Levels and Dementia.

Authors:  Ju-Wan Kim; Robert Stewart; Hee-Ju Kang; Kyung-Yeol Bae; Sung-Wan Kim; Il-Seon Shin; Jin-Sang Yoon; Jae-Min Kim
Journal:  Front Psychiatry       Date:  2018-11-19       Impact factor: 4.157

5.  Morphometric Changes to Corneal Dendritic Cells in Individuals With Mild Cognitive Impairment.

Authors:  Cirous Dehghani; Shaun Frost; Rajiv Jayasena; Christopher Fowler; Colin L Masters; Yogesan Kanagasingam; Haihan Jiao; Jeremiah K H Lim; Holly R Chinnery; Laura E Downie
Journal:  Front Neurosci       Date:  2020-12-09       Impact factor: 4.677

Review 6.  Metabolic Syndrome and Vascular-Associated Cognitive Impairment: a Focus on Preclinical Investigations.

Authors:  Trisha A Jenkins
Journal:  Curr Diab Rep       Date:  2022-06-23       Impact factor: 5.430

Review 7.  OxInflammation: From Subclinical Condition to Pathological Biomarker.

Authors:  Giuseppe Valacchi; Fabio Virgili; Carlo Cervellati; Alessandra Pecorelli
Journal:  Front Physiol       Date:  2018-07-09       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.